Biology of Blood and Marrow Transplantation
Volume 16, Issue 2 , Pages 215-222 , February 2010

Impact of Cytomegalovirus (CMV) Reactivation after Umbilical Cord Blood Transplantation

  • Jill C. Beck

      Affiliations

    • Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota
    • ,
  • John E. Wagner

      Affiliations

    • Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Todd E. DeFor

      Affiliations

    • Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Claudio G. Brunstein

      Affiliations

    • Department of Medicine, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Mark R. Schleiss

      Affiliations

    • Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Jo-Anne Young

      Affiliations

    • Department of Medicine, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Daniel H. Weisdorf

      Affiliations

    • Department of Medicine, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Sarah Cooley

      Affiliations

    • Department of Medicine, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Jeffrey S. Miller

      Affiliations

    • Department of Medicine, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Michael R. Verneris

      Affiliations

    • Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota
    • Corresponding Author InformationCorrespondence and reprint requests: Michael R. Verneris, MD, Department of Pediatrics, University of Minnesota, 425 East River Road, Suite 660, Minneapolis, MN 55455.

Received 13 July 2009 ,Accepted 24 September 2009.

  • Image Result

    Cumulative incidence of CMV reactivation by conditioning regimen. There is no significant difference between the myeloablative and nonmyeloablative conditioning.

    Cumulative incidence of CMV reactivation by conditioning regimen. There is no significant difference between the myeloablative and nonmyeloablative conditioning.

  • Image Result

    Cumulative incidence of CMV reactivation by GVHD prophylaxis regimen. There is no significant difference between the ATG containing regimen (CsA/methylprednisone/ATG) and the non-ATG containing regime

    Cumulative incidence of CMV reactivation by GVHD prophylaxis regimen. There is no significant difference between the ATG containing regimen (CsA/methylprednisone/ATG) and the non-ATG containing regimen (CsA/MMF).

 Financial disclosure: See Acknowledgments on page 221.

PII: S1083-8791(09)00437-6

doi: 10.1016/j.bbmt.2009.09.019

Biology of Blood and Marrow Transplantation
Volume 16, Issue 2 , Pages 215-222 , February 2010

Article Tools

* Image Usage & Resolution